These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6106281)

  • 21. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
    Kornerup HJ; Pedersen EB; Pedersen A; Pedersen G; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():49-52. PubMed ID: 7001422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
    Glorioso N; Madeddu P; Dessì Fulgheri P; Sanna G; Fiori C; Dettori S; Cocco F; Rappelli A
    G Ital Cardiol; 1981; 11(12):2117-25. PubMed ID: 6125451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blockade for hypertension.
    Drug Ther Bull; 1974 Apr; 12(9):33-5. PubMed ID: 4156667
    [No Abstract]   [Full Text] [Related]  

  • 24. [beta Blocking agents in arterial hypertension].
    Zacchello F
    Minerva Pediatr; 1977 Mar; 29(7):435-8. PubMed ID: 17060
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of a beta-blocker on plasma renin activity of hypertensive patients.
    Salvetti A; Arzilli F; Baccini C
    J Nucl Biol Med; 1973; 17(3):142-50. PubMed ID: 4147719
    [No Abstract]   [Full Text] [Related]  

  • 26. Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.
    Pedrinelli R; Abdel-Haq B; Magagna A; Leto di Priolo S; Simonini N; Salvetti A
    Int J Clin Pharmacol Res; 1984; 4(2):155-63. PubMed ID: 6147320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oxoprenolol and plasmatic renin activity in essential hypertension: preliminary data].
    Del Guercio R; Conti G; De Buono AF; Gentile S; Saponara A; Leone C; Colacurcio M
    Boll Soc Ital Biol Sper; 1978 Nov; 54(21):2082-5. PubMed ID: 751662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the action of beta adrenergic blocking agents on platelet adhesiveness and fibrinolysis in atherosclerosis].
    Nicolaescu V; Ionăşescu R; Pompilian P; Teodorescu P
    Med Interna (Bucur); 1970 Dec; 22(12):1497-503. PubMed ID: 4396020
    [No Abstract]   [Full Text] [Related]  

  • 29. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term increase in prostaglandin I2 synthesis caused by cicletanine in patients with essential hypertension.
    Yasu T; Imanishi M; Kimura G; Tsuji T; Matsuoka H; Kuramochi M; Omae T
    Am J Hypertens; 1995 Sep; 8(9):944-8. PubMed ID: 8541011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of anapriline on myocardial contraction and systemic vascular resistance in patients with stage II hypertension].
    Tokarenko II
    Klin Med (Mosk); 1990 Dec; 68(12):15-7. PubMed ID: 1982154
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of crystepin in combination with obsidan in patients with diabetes mellitus with arterial hypertension].
    Leviashvili BI
    Klin Med (Mosk); 1989 Mar; 67(3):34-7. PubMed ID: 2747151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment.
    Davies R; Payne NN; Slater JD
    Am J Cardiol; 1976 Mar; 37(4):637-41. PubMed ID: 3963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of severe hypertension with nifedipine in combination with clonidine or propranolol.
    Imai Y; Abe K; Otsuka Y; Irokawa N; Yasujima M; Saito K; Sakurai Y; Chiba S; Ito T; Sato M; Haruyama T; Miura Y; Yoshinaga K
    Arzneimittelforschung; 1980; 30(4):674-8. PubMed ID: 6994751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prorenin and beta-blockade in hypertension.
    McKenna F; Davison AM
    Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
    Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The efficacy of proxodolol in patients with stable arterial hypertension].
    Metelitsa VI; Ostrovskaia TP; Duda SG; Shastun RS; Chel'dieva EIa; Simonov DV; Kalinin AL; Kekshina MS
    Eksp Klin Farmakol; 1994; 57(3):38-42. PubMed ID: 7914118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of angiotensin II upon platelet adhesiveness and the thrombelastogram in patients with essential arterial hypertension.
    Uza G; Crîsnic I
    Pathol Eur; 1975; 10(4):327-32. PubMed ID: 1208124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The renin-aldosterone system in essential hypertension--hypotensive action of beta adrenergic blocking agents and variation of the renin-aldosterone system (author's transl)].
    Hata S
    Nihon Naibunpi Gakkai Zasshi; 1977 Oct; 53(10):1129-39. PubMed ID: 22466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.